- Home
- PKE vs PRQR Comparison
PKE vs PRQR Comparison
Compare PKE & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- PRQR
- Stock Information
- Founded
- PKE 1954
- PRQR 2012
- Country
- PKE United States
- PRQR Netherlands
- Employees
- PKE N/A
- PRQR N/A
- Industry
- PKE Military/Government/Technical
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- PRQR Health Care
- Exchange
- PKE Nasdaq
- PRQR Nasdaq
- Market Cap
- PKE 285.7M
- PRQR 309.5M
- IPO Year
- PKE N/A
- PRQR 2014
- Fundamental
- Price
- PKE $13.24
- PRQR $1.14
- Analyst Decision
- PKE
- PRQR Strong Buy
- Analyst Count
- PKE 0
- PRQR 6
- Target Price
- PKE N/A
- PRQR $8.50
- AVG Volume (30 Days)
- PKE 68.0K
- PRQR 628.0K
- Earning Date
- PKE 05-29-2025
- PRQR 05-08-2025
- Dividend Yield
- PKE 3.78%
- PRQR N/A
- EPS Growth
- PKE N/A
- PRQR N/A
- EPS
- PKE 0.36
- PRQR N/A
- Revenue
- PKE $61,420,000.00
- PRQR $20,235,014.00
- Revenue This Year
- PKE N/A
- PRQR $6.44
- Revenue Next Year
- PKE N/A
- PRQR N/A
- P/E Ratio
- PKE $36.75
- PRQR N/A
- Revenue Growth
- PKE 15.45
- PRQR 196.41
- 52 Week Low
- PKE $11.96
- PRQR $1.07
- 52 Week High
- PKE $15.57
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PKE 49.18
- PRQR 28.23
- Support Level
- PKE $12.99
- PRQR $1.08
- Resistance Level
- PKE $13.41
- PRQR $1.26
- Average True Range (ATR)
- PKE 0.58
- PRQR 0.13
- MACD
- PKE 0.05
- PRQR 0.02
- Stochastic Oscillator
- PKE 64.14
- PRQR 21.87
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.